• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Omalizumab for the treatment of chronic inducible urticaria in 80 patients.

作者信息

Exposito-Serrano V, Curto-Barredo L, Aguilera Peiro P, Gómez Armayones S, Serra-Baldrich E, Spertino J, Bonfill Ortí M, Figueras Nart I, Melé-Ninot G, Baliu-Piqué C, Sala Cunill A, Labrador-Horrillo M, Guilabert Vidal A, Fernández Chico N, Giménez-Arnau A M

机构信息

Departments of Dermatology at, Department of Dermatology, Hospital Universitari Parc Taulí. Sabadell.

Department of Dermatology, Hospital del Mar.

出版信息

Br J Dermatol. 2021 Jan;184(1):167-168. doi: 10.1111/bjd.19425. Epub 2020 Sep 2.

DOI:10.1111/bjd.19425
PMID:32730636
Abstract
摘要

相似文献

1
Omalizumab for the treatment of chronic inducible urticaria in 80 patients.奥马珠单抗治疗80例慢性诱导性荨麻疹
Br J Dermatol. 2021 Jan;184(1):167-168. doi: 10.1111/bjd.19425. Epub 2020 Sep 2.
2
Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.奥马珠单抗对慢性自发性荨麻疹合并多种慢性诱导性荨麻疹患者有效。
Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.
3
Real world evidence on treatment of chronic spontaneous urticaria with omalizumab: Preliminary data.关于奥马珠单抗治疗慢性自发性荨麻疹的真实世界证据：初步数据。
Dermatol Ther. 2020 Jul;33(4):e13458. doi: 10.1111/dth.13458. Epub 2020 Jun 7.
4
Omalizumab in chronic inducible urticaria: A retrospective, real-life study.奥马珠单抗治疗慢性诱导性荨麻疹：一项回顾性、真实世界研究。
Ann Dermatol Venereol. 2021 Dec;148(4):262-265. doi: 10.1016/j.annder.2021.04.010. Epub 2021 Jul 8.
5
Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals.慢性荨麻疹患者中黄热病疫苗的不良事件：与健康个体相比，接受或未接受奥马珠单抗治疗患者的评估
An Bras Dermatol. 2021 Jul-Aug;96(4):497-499. doi: 10.1016/j.abd.2020.09.009. Epub 2021 May 15.
6
Effectiveness and tolerability of personalized omalizumab treatment in patients with chronic inducible urticaria.个性化奥马珠单抗治疗慢性诱导性荨麻疹患者的有效性和耐受性
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3227-3229. doi: 10.1016/j.jaip.2021.04.034. Epub 2021 Apr 26.
7
Effectiveness of Omalizumab in Patients with Chronic Inducible Urticaria: real-life experience from two UCARE centres.奥马珠单抗治疗慢性诱导性荨麻疹患者的有效性：来自两个UCARE中心的真实病例经验。
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e679-e682. doi: 10.1111/jdv.17385. Epub 2021 Jun 12.
8
"Omalizumab plus": Combining omalizumab with immunosuppression for treatment of refractory chronic urticaria: A multicenter UK series.“奥马珠单抗联合疗法”：奥马珠单抗与免疫抑制联合用于治疗难治性慢性荨麻疹：一项英国多中心研究系列
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1400-1401.e2. doi: 10.1016/j.jaip.2020.10.056. Epub 2020 Nov 9.
9
[HOW PERIPHERAL BASOPHILS IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA ARE CHANGED WITH OMALIZUMAB TREATMENT?].[慢性自发性荨麻疹患者外周嗜碱性粒细胞经奥马珠单抗治疗后有何变化？]
Arerugi. 2021;70(9):1196-1199. doi: 10.15036/arerugi.70.1196.
10
Effective omalizumab interval prolongation in the treatment of chronic urticaria.奥马珠单抗治疗慢性荨麻疹时有效延长给药间隔时间
J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3667-3668.e1. doi: 10.1016/j.jaip.2020.06.056. Epub 2020 Jul 14.

引用本文的文献

1
Decoding the variability in clinical and laboratory profiles of Chronic Inducible Urticaria vs. Chronic Spontaneous Urticaria - a retrospective study from a tertiary care center.解析慢性诱导性荨麻疹与慢性自发性荨麻疹的临床和实验室特征变异性-来自三级护理中心的回顾性研究。
Arch Dermatol Res. 2024 Oct 22;316(10):703. doi: 10.1007/s00403-024-03447-6.
2
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.奥马珠单抗治疗慢性诱导性荨麻疹（CIndU）有效且安全：来自大型多国UCARE研究的真实世界数据。
Allergy. 2025 Feb;80(2):489-499. doi: 10.1111/all.16334. Epub 2024 Oct 8.
3
New insights into chronic inducible urticaria.
慢性诱导性荨麻疹的新见解。
Curr Allergy Asthma Rep. 2024 Aug;24(8):457-469. doi: 10.1007/s11882-024-01160-y. Epub 2024 Jul 19.
4
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.奥马珠单抗治疗慢性自发性荨麻疹患者：现状的叙述性综述
Dermatol Ther (Heidelb). 2023 Nov;13(11):2573-2588. doi: 10.1007/s13555-023-01040-9. Epub 2023 Sep 30.
5
Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome.奥马珠单抗治疗慢性自发性荨麻疹和慢性诱导性荨麻疹：疗效的真实世界研究及治疗结局的预测因素。
J Korean Med Sci. 2022 Jul 11;37(27):e211. doi: 10.3346/jkms.2022.37.e211.
6
IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.慢性诱导性荨麻疹中的IgE与高亲和力IgE受体：发病机制及管理意义
Clin Transl Allergy. 2022 Feb 1;12(2):e12117. doi: 10.1002/clt2.12117. eCollection 2022 Feb.
7
Expert consensus on the use of omalizumab in chronic urticaria in China.中国奥马珠单抗治疗慢性荨麻疹专家共识
World Allergy Organ J. 2021 Dec 5;14(11):100610. doi: 10.1016/j.waojou.2021.100610. eCollection 2021 Nov.
8
Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.慢性荨麻疹：对疾病的认识和临床管理的进展。
Clin Rev Allergy Immunol. 2021 Dec;61(3):424-448. doi: 10.1007/s12016-021-08886-x. Epub 2021 Sep 16.
9
Anti-IgE for the Treatment of Chronic Urticaria.抗IgE用于治疗慢性荨麻疹。
Immunotargets Ther. 2021 Feb 17;10:27-45. doi: 10.2147/ITT.S261416. eCollection 2021.